These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7002443

  • 1. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
    Bergquist C, Nillius SJ, Wide L.
    Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
    [Abstract] [Full Text] [Related]

  • 2. Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.
    Bergquist C, Nillius SJ, Wide L.
    Contraception; 1980 Oct; 22(4):341-7. PubMed ID: 7004772
    [Abstract] [Full Text] [Related]

  • 3. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
    Skarin G, Nillius SJ, Wide L.
    Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ, Bergquist C, Wide L.
    Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
    [Abstract] [Full Text] [Related]

  • 5. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ, Bergquist C, Wide L.
    Int J Fertil; 1980 Jun; 25(3):239-46. PubMed ID: 6108935
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM, Thompson IE, Taymor ML.
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist.
    Bergquist C, Nillius SJ, Wide L.
    Contraception; 1979 May; 19(5):497-506. PubMed ID: 380892
    [Abstract] [Full Text] [Related]

  • 9. Failure to induce early abortion by huge doses of a superactive LRH agonist in women.
    Skarin G, Nillius SJ, Wide L.
    Contraception; 1982 Nov; 26(5):457-63. PubMed ID: 6819111
    [Abstract] [Full Text] [Related]

  • 10. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical observations on LRH-A used for contraception by luteolysis in normal women--analysis of 88 cases].
    Lu RK, Chen HY, Liu Y, Zhang L, He YJ, Ge LJ, Yuan XW, Qui XD.
    Shengzhi Yu Biyun; 1987 Mar; 7(1):39-40, 45-7. PubMed ID: 12341309
    [Abstract] [Full Text] [Related]

  • 13. Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility.
    Sheehan KL, Casper RF, Yen SS.
    Fertil Steril; 1982 Feb; 37(2):209-12. PubMed ID: 7037463
    [Abstract] [Full Text] [Related]

  • 14. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C, Nillius SJ, Wide L, Lindgren A.
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [Abstract] [Full Text] [Related]

  • 15. The induction of premature luteolysis in normal women--follicular phase luteinizing hormone secretion and corpus luteum function in the subsequent cycle.
    Soules MR, Bremner WJ, Dahl KD, Rivier JE, Vale WW, Clifton DK.
    Am J Obstet Gynecol; 1991 Apr; 164(4):989-94; discussion 994-6. PubMed ID: 2014851
    [Abstract] [Full Text] [Related]

  • 16. Chronic effects of the stimulatory luteinizing hormone-releasing hormone analogue D-Ser (TBU) 6-EA 10-LRH on the gonadotrophin and gonadal steroid secretion in women with amenorrhoea.
    Skarin G, Nillius SJ, Wide L.
    Ups J Med Sci; 1980 Apr; 85(2):103-12. PubMed ID: 6787767
    [Abstract] [Full Text] [Related]

  • 17. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S, Charbonnel B, Massai MR, Marraoui J, Spitz I, Bouchard P.
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [Abstract] [Full Text] [Related]

  • 18. [Clinical study on LRH-A contraception by luteolysis].
    Lu RK.
    Zhonghua Fu Chan Ke Za Zhi; 1989 Jan; 24(1):26-8, 58. PubMed ID: 2667912
    [Abstract] [Full Text] [Related]

  • 19. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue - a new approach to birth control?
    Nillius SJ, Bergquist C, Wide L.
    Contraception; 1978 Jun; 17(6):537-44. PubMed ID: 363344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.